EGA
PTX

Eagle Global Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Eagle Global Advisors’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-14,126
Closed -$148K – 412
2016
Q1 		$148K Buy
14,126
+3,990
+39% +$79.3K 0.01% 337
2015
Q4 		$299K Buy
10,136
+5,270
+108% +$159K 0.01% 277
2015
Q3 		$154K Buy
4,866
+1,076
+28% +$51.5K 0.01% 335
2015
Q2 		$224K Sell
3,790
-325
-8% -$22.9K 0.01% 321
2015
Q1 		$440K Buy
+4,115
New +$392K 0.01% 207

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $783M AUM 81.58% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Eagle Global Advisors's PTX Position: Q2 2016 in Review

Eagle Global Advisors sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 14,126 shares — an estimated $148K sold.

Eagle Global Advisors first reported a position in PTX in Q1 2015 and held it in 5 quarters. The position peaked at $440K in Q1 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

  • Eagle Global Advisors reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • Eagle Global Advisors sold 14,126 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $148K.
  • Eagle Global Advisors first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2015 and held it in 5 quarters.
  • Eagle Global Advisors's Pernix Therapeutics Holdings, Inc. position peaked at $440K in Q1 2015.
  • 56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Eagle Global Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.